Klaus R. Veitinger Dr.

Director, Intercept Pharmaceuticals.

Companies

scPharmaceuticals (United States)Board member Nov 21, 2017 to now¹
TricidaBoard member Jun 27, 2018 to Jun 16, 2022²
Intercept PharmaceuticalsBoard member Oct 10, 2012 to Nov 27, 2015³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARscPharmaceuticals (United States), Board member
2
SEC EDGARTricida, Board member
3
SEC EDGARIntercept Pharmaceuticals, Board member